End-of-day quote
Other stock markets
|
||
- | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 01/17/01 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 25/17/25 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 01/22/01 |
Corporate Officer/Principal | - | 01/17/01 | |
Corporate Officer/Principal | - | 16/20/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 17/19/17 |
Bruce Resnick
BRD | Director/Board Member | - | 17/19/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,944,971 | 36,835,813 ( 94.58 %) | 421,677 ( 1.083 %) | 94.58 % |
Company contact information
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.comSector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- Stock
- Stock
- Company Spark Therapeutics Inc